IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q4 FY20 results · Jan–Mar 2020
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹441.46 crore (up 4.5% from Q4 FY19) and net profit of ₹90.26 crore (down 11.2% from Q4 FY19) for Q4 FY20 (Jan–Mar 2020), on a standalone basis.
| Item | Q4 FY20 | Q4 FY19 | YoY | Q3 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 441.46 | 422.29 | +4.5% | 511.25 | −13.7% |
| Other income | 5.35 | 2.20 | +143.2% | 3.96 | +35.1% |
| Total income | 446.81 | 424.49 | +5.3% | 515.21 | −13.3% |
| Profit before tax | 130.08 | 142.52 | −8.7% | 150.76 | −13.7% |
| Net profit for the period | 90.26 | 101.65 | −11.2% | 98.01 | −7.9% |
| EPS, basic (₹) | 31.74 | 18.08 | +75.6% | 17.22 | +84.3% |
| Net margin (%) | 20.4 | 24.1 | 19.2 |
Standalone
- Filed with BSE
- 13 Jun 2020, 08:36 IST
- Board meeting
- 12 Jun 2020
- Period
- 01 Jan 2020 to 31 Mar 2020
- Review status
- Audited
- Source
- XBRL filing on BSE